Ticarcillin plus clavulanic acid versus moxalactam in the treatment of skin and soft tissue infections
- 29 November 1985
- journal article
- clinical trial
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 79 (5), 126-129
- https://doi.org/10.1016/0002-9343(85)90144-5
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolatesAntimicrobial Agents and Chemotherapy, 1984
- Pharmacokinetics and tissue penetration of ticarcillin combined with clavulanic acidAntimicrobial Agents and Chemotherapy, 1983
- In Vitro Activity of Mezlocillin and Its Related Compounds Against Aerobic and Anaerobic BacteriaAntimicrobial Agents and Chemotherapy, 1979
- Clavulanic Acid, a Novel Inhibitor of β-LactamasesAntimicrobial Agents and Chemotherapy, 1978
- Combined Activity of Clavulanic Acid and Ticarcillin Against Ticarcillin-Resistant, Gram-Negative BacilliAntimicrobial Agents and Chemotherapy, 1978
- Clavulanic Acid: a Beta-Lactamase-Inhibiting Beta-Lactam from Streptomyces clavuligerusAntimicrobial Agents and Chemotherapy, 1977
- Comparative In Vitro Activity and Clinical Pharmacology of Ticarcillin and CarbenicillinAntimicrobial Agents and Chemotherapy, 1975